The following is a summary of the Forian Inc. (FORA) Q3 2024 Earnings Call Transcript:

Financial Performance:

• Forian Inc. reported a third-quarter revenue of $4.7 million, down from $5.3 million year-over-year.

• The company experienced a net loss of $0.2 million, compared to a net income of $4.3 million in the same period last year.

• Adjusted EBITDA for the quarter was $0.2 million, a significant decrease from $1.1 million year-over-year.

Business Progress:

• Forian intends to break out of its consistent revenue range in 2025, supported by increased sales momentum in health care services and life sciences.

• The acquisition of Kyber Data Science is expected to expand Forian's addressable market and enhance its data science and predictive analytic capabilities.

Opportunities:

• The acquisition of Kyber Data Science targets new market opportunities by including financial service customers, which aligns well with Forian's life science customer base.

• Forian continues to actively evaluate strategic opportunities, potentially including partnerships and acquisitions to enhance and expand their product portfolio and client base.

Risks:

• Revenue impacts from new sales have not been fully realized, posing a risk of delayed financial improvement.

• Previous customer attrition and data disruptions have been significant headwinds, reflected in stagnant revenue growth.

More details: Forian IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.